Kjeld Schmiegelow, MD, DMSci - Asparaginase Therapy in Children and Young Adults With ALL/LBL: When You Need to Switch

What this episode covers

Visit https://www.peervoice.com/BYU860 to view the entire programme with slides. After completing “Kjeld Schmiegelow, MD, DMSci - Asparaginase Therapy in Children and Young Adults With ALL/LBL: When You Need to Switch”, participants will be able to: Summarise the current treatment guidelines and the importance of asparaginase therapy for children and adolescents/young adults with acute lymphoblastic leukaemia/lymphoblastic lymphoma (ALL/LBL); Describe the consequences of patients developing hypersensitivity to or silent deactivation of asparaginase; and Identify practical protocols for the management and monitoring of patients on asparaginase therapy.

Distinct summary based on available episode metadata or transcript content.